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We estimate the relative transmission rate in early versus later
infection among men who have sex with men (MSM) in
San Francisco, California, by studying the characteristics of
a sample of transmitters, recruited through newly diagnosed,
recently infected MSM between 1996 and 2009. Of 36 trans-
mitters identiﬁed, 9 were determined on the basis of testing
history and serologic testing to have been recently infected.
The unadjusted odds ratio of transmitting during early infec-
tion was 15.2 (95% conﬁdence interval [CI], 6.3–33.4;
P < .001); the odds ratio was 8.9 (95% CI, 4.1–19.4) after ad-
justment for self-reported antiretroviral treatment. This high
transmissibility could be due to both high infectiousness and
high rates of sex partner change or concurrent partnerships.
Keywords. HIV; transmission rate; early infection; men
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Estimates of the relative transmission rate of human immuno-
deﬁciency virus (HIV) during early infection are essential for
understanding the dynamics of transmission and the likely
impact of intervention programs [1]. Early infection is associat-
ed with high transmission rates among heterosexuals, but there
are limited estimates among men who have sex with men
(MSM) [2]. High infectivity in early infection is thought to be
due to a combination of high viral loads, viral phenotype, or
host risk factors, such as coinfection. Studies that stratify trans-
mission rates among MSM by viral load show a strong associa-
tion between high viral loads and transmission rates, suggesting
that early infection, characterized by high viral loads in semen
[3], is highly infectious among MSM. A recent review of HIV
transmission by anal intercourse found no signiﬁcant difference
in transmission probability per unprotected penile-anal
act among the heterosexual population, compared with the
MSM population [4], and early infection has been shown to
be highly infectious among heterosexuals [5, 6].
Phylogenetic studies of MSM-dominated epidemics have
shown a high degree of clustering among samples from early
infection, suggesting that chains of transmission during early
infection are contributing to a large proportion of transmissions
(from 10% to 50% [7]), a consequence of both differential infec-
tiousness, the stage of the epidemic, and the sexual risk behavior
in the population [8]. Direct estimation of the relative infec-
tiousness of early infection in this way is inherently challenging
but can be done well [9]. An alternative approach is to use viral
phylogenies to identify likely transmission pairs within a longi-
tudinally studied cohort, using clinical data to infer the direc-
tion of transmission, and to compare the pairs to randomly
chosen members of the cohort to quantify the risk factors asso-
ciated with transmission; Fisher et al estimated a rate ratio of
transmission during early infection of 3.88 (95% conﬁdence in-
terval [CI], 1.76–8.55; P = .0008) [10]. As with all indirect meth-
ods, including the method used in the analysis described below,
these estimates are affected by the dynamics of each particular
epidemic, including variable behavior, diagnosis, and treatment
patterns. Since all of these estimates each have their own limi-
tations, multiple estimates of transmission rates using different
methods are needed to develop a better understanding of the
dynamics of the HIV epidemic.
We estimated the relative transmission rate of early infection
amongMSM in San Francisco, California, by comparing the char-
acteristics of a sample of transmitters with those of the general
HIV-infected population. This is similar to a case-control study
in which cases are source partners known to have transmitted
HIV to their partners and controls are the HIV-infected popula-
tion. We assume that the source partners are a random sample of
transmitters, ie, that the characteristics of both recent and chronic
transmitters are similar to the characteristic of individuals with
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this stage of infection in the larger population. This is similar to
the method used by Fisher et al [10] but differs principally by the
methods used to identify transmitters and to stage early infection.
METHODS
The relative infectiousness of recently and chronically infected
individuals can be estimated by comparing the distribution of
recently infected individuals in a sample of transmitters with
that in the estimated HIV-infected MSM population at the
time of recruitment. A group of HIV-infected MSM were iden-
tiﬁed by recruitment of their newly infected sex partners and
genetic conﬁrmation of transmission (Supplementary Materi-
als) [11]. This was a secondary analysis of anonymized data.
The present analysis makes an assumption that the method
of selection gives an unbiased sample of transmitters because
they were all recruited in a similar way. For this reason, we in-
cluded only transmitters who were initially identiﬁed as being a
potential source partner for a new recently infected index case.
To estimate the role of early infection in transmission, the stage
of infection for the majority of transmitters was characterized
using an enzyme immunoassay (EIA) (Supplementary Materials).
To allow for reduced transmission during chronic infection
due to treatment, which could inﬂate the estimate of the relative
transmissibility during early infection, treatment status was also
requested from each transmitter.
The comparison group for this analysis was the HIV-infected
MSM population in San Francisco. The San Francisco Depart-
ment of Public Health publishes yearly estimates of the HIV-
infected population, including those with undiagnosed infec-
tion and those with incident infection (Supplementary Materi-
als). Since newly infected individuals were only in the early
phase of infection for a portion of the year, we approximated
their presence in the epidemic by using the duration of the
mean interval between the time at which an HIV-infected
individual tests positive for HIV antibody by a sensitive EIA
and the time at which the individual tests negative for HIV an-
tibody by a less sensitive EIA, with a cutoff of approximately
164 days [12]. If k is deﬁned as the number of new infections
in a given year, approximately 164/365*k person-years of poten-
tial transmission during early infection were assumed to have
occurred.
The distribution of transmitters and HIV-infected individu-
als can be compared to estimate the odds ratio (OR) of transmis-
sion during early infection; that is, the relative transmission rate
in early infection, which is a combination of biological and be-
havioral factors. These ORs were obtained using standard meth-
ods, implemented using the function epi.2by2 in the package
epiR for R, including the Breslow Day test for homogeneity
across years [13].
RESULTS
From 1997 to 2009, 656 index cases with early infection were
seen, and partners were identiﬁed in 69 (10.5%; from 2000 to
2003, when the most partners were recruited, transmitters
were successfully identiﬁed for 43 of 209 index cases [21%]).
Twenty-seven transmitting pairs were excluded because (1)
the index case was found not to be recently infected on further
analysis (6 pairs), (2) the transmitter was already in the cohort
(11 pairs), (3) staging information was unavailable for the
source partner (9 pairs), or (4) a third individual was possibly
the source for both partners (1 pair). This left 42 transmitting
pairs, of whom 36 were MSM. Of these, 9 had individuals who
were in the early phase of infection, and the remaining 27 had
individuals whowere in the chronic phase of infection (Table 1).
The mean duration of infection for these 9 recently infected
transmitters was estimated to be 70 days (median duration, 72
days; range, 24–153 days). Of the 27 chronic transmitters stud-
ied here, 6 were reported as receiving or probably receiving
Table 1. Characteristics of Human Immunodeﬁciency Virus (HIV) Transmitters and the HIV-Infected Population in San Francisco
Year
HIV Transmitters HIV-Infected Population
Early
Chronic Early Chronic
Untreated Treated Total No. (Whole Year) Untreated Treated Total No.
1997 0 (0) 2 (100) 0 (0) 2 283 (2) 7071 (59) 4628 (39) 11 983
1998 1 (50) 1 (50) 0 (0) 2 399 (3) 6385 (52) 5586 (45) 12 370
2000 2 (22) 6 (67) 1 (11) 9 631 (5) 6142 (47) 6371 (48) 13 146
2001 2 (22) 6 (67) 1 (11) 9 748 (6) 5984 (44) 6801 (50) 13 534
2002 1 (17) 2 (33) 3 (50) 6 752 (5) 5876 (43) 7193 (52) 13 822
2003 1 (33) 2 (67) 0 (0) 3 757 (5) 5768 (41) 7585 (54) 14 111
2004 0 (0) 1 (100) 0 (0) 1 762 (5) 5819 (40) 7817 (54) 14 399
2008 2 (67) 1 (33) 0 (0) 3 697 (5) 5079 (35) 8869 (61) 14 646
2009 0 (0) 0 (0) 1 (100) 1 659 (5) 4689 (32) 9131 (63) 14 480
Overall 9 (25) 21 (58) 6 (17) 36 5688 (5) 52 813 (43) 63 981 (52) 122 491
Data are no. (%) of individuals, unless otherwise indicated. Additional information is available in the Supplementary Materials.
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antiretroviral treatment (ART) for HIV, although most if not all
of these treated sources lacked evidence of having achieved and
maintained suppression of virus to levels below the limits of de-
tection. Newly infected individuals made up approximately 5%
of the HIV-infected population in the whole year (scaling to ac-
count for the proportion of the year in early infection, this is
approximately 2%) but 25% of transmitters (Table 1), suggest-
ing that recently infected individuals are highly overrepresented
in transmitters and contribute a considerable proportion of on-
ward transmission. Conversely, treated chronically infected in-
dividuals are underrepresented in the transmitters (17%),
compared with the HIV-infected population (52%; Table 1).
Early infection was estimated to be a highly infectious period
(crude OR [vs chronic infection], 15.2; 95% CI, 6.3–33.4;
P < .001), with evidence that the transmissibility was not the
same across years (P = .69). The analysis also suggested a
marked reduction in the odds of transmitting due to treatment
(OR [vs no treatment], 0.25; 95% CI, .08–.63; P = .001). After
adjustment for the impact of treatment, the OR for early infec-
tion decreased to 8.9 (95% CI, 4.1–19.4; P < .001).
To investigate the impact of the uncertainty in the duration of
early infection, the estimates were repeated for the 95% CI on
the estimated duration of early infection in the assay [12]; for
139 days, the adjusted OR was 10.4 (95% CI, 4.8–22.8), and
for 199 days, the adjusted OR was 7.3 (95% CI, 3.3–15.9). Sen-
sitivity to overestimation of the number of early infections was
considered by rerunning the analysis at a cutoff of 0.75 for the
early infection assay and a consequent duration of 129 days
[12], giving an additional 2 cases during chronic infection
and an adjusted OR of 7.0 (95% CI, 3.4–18.7).
DISCUSSION
When an event is rare, the OR is a good approximation of the
relative risk. Therefore, an OR can be compared with previous
estimates of the relative transmission rate of early infection. An
estimated 4–19-fold greater adjusted odds of transmission dur-
ing early infection, compared with chronic infection, lies at the
middle to higher end of estimates for both MSM and heterosex-
ual transmission [4, 14] but overlaps estimates for heterosexual
partners in general [8]and for heterosexual partners who engage
in anal sex [4]. The estimated reduction in transmission is based
on self-reported ART use without conﬁrmation of viral suppres-
sion and is thus unsurprisingly lower than that associated with
validated ART use with conﬁrmed viral suppression [15]. It
should be remembered that the estimate of transmissibility dur-
ing early infection is a combination of both behavior and biol-
ogy, the individual effects of which cannot be disentangled with
this study design.
The role of high infectivity in population-level transmission
is limited by the short duration of this stage of infection but will
be increased by high rates of partner change [8]. Because of
inevitable delays in identifying transmission and transmitters,
our deﬁnition of early infection at the time of transmission is
deﬁned by the stage of infection of the transmitter at the time
of identiﬁcation some months later. We therefore cannot be cer-
tain of the exact stage of infection at the time of transmission,
but this increased risk is an estimate of infectiousness during
the ﬁrst 6–9 months of infection. Given this interval, these
are very high estimates. A worrying consequence of high trans-
missibility for MSM during early infection is that it would speed
the epidemic growth rate in expanding or re-expanding MSM
epidemics. Thus, this study highlights the need for sustained
HIV-prevention efforts to help reduce HIV transmission
among MSM and for ﬁnding ways to more effectively diagnose
infection and treat MSM with early HIV infection to prevent
reversal of hard-won gains.
The main limitations of our study are the assumptions that
the source population in this study represents all sources in
San Francisco and that our data are an unbiased sample of
transmitters. Short of performing a prospective study of all po-
tential transmitters and their partners, the study design used is
the only one we are aware of to address these questions.
Although we are not aware of any systematic bias in our as-
sumption, it is possible that the networks dominated by trans-
misssion in early infection in San Francisco are more integrated
and, hence, more likely to present to a research setting as iden-
tiﬁed partners. Also, during the period of observation, a sub-
stantial proportion of the chronically infected population in
San Francisco was receiving effective ART. This highlights the
need for further studies of this type.
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